Use of knockout technology to resolve pharmacological problems
- PMID: 17099720
- PMCID: PMC2013846
- DOI: 10.1038/sj.bjp.0706941
Use of knockout technology to resolve pharmacological problems
Abstract
Knock-out (KO) mouse technology has given pharmacologists a powerful tool to study function in the absence of selective antagonists or inhibitors. Such KO technology can confirm predicted function, serendipitously reveal unrecognized function, or help define the mode of action of a drug. In this issue, Liles et al. demonstrate, employing mice unable to synthesize noradrenaline due to the KO of the dopamine-beta-hydroxylase gene, that the sympathomimetic actions of ephedrine are directly, rather than indirectly, mediated. This may end 50 years of debate about the actions of ephedrine.
Comment on
-
Pressor responses to ephedrine are not impaired in dopamine beta-hydroxylase knockout mice.Br J Pharmacol. 2007 Jan;150(1):29-36. doi: 10.1038/sj.bjp.0706942. Epub 2006 Nov 13. Br J Pharmacol. 2007. PMID: 17099719 Free PMC article.
References
-
- Altman JD, Trendelenburg AU, MacMillan L, Bernstein D, Limbird L, Starke K, et al. Abnormal regulation of the sympathetic nervous system in alpha2A-adrenergic receptor knockout mice. Mol Pharmacol. 1999;56:154–161. - PubMed
-
- Ho SL, Honner V, Docherty JR. Investigation of the subtypes of alpha2-adrenoceptor mediating prejunctional inhibition in rat atrium and cerebral cortex. Naunyn Schmiedebergs Arch Pharmacol. 1998;357:634–639. - PubMed
-
- Kawasuji T, Koike K, Saito H. Chronotropic effects of optical isomers of ephedrine and methylephedrine ion the isolated rat right atria and in vitro assessment of direct and indirect actions on beta1-adrenoceptors. Biol Pharm Bull. 1996;19:1423–1428. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials